The global meningococcal vaccines market size is expected to reach a value of USD 5.81 billion by 2027 witnessing a CAGR of 8.9% during the forecast period 2021-2027.
View Complete Report: https://precisionbusinessinsights.com/market-reports/meningococcal-vaccines-market/
Meningococcal Vaccines Market Segmants:
By Type:
Meningococcal Conjugate Vaccines,
Meningococcal Polysaccharide Vaccine,
Serogroup B Meningococcal Vaccine
By End-user:
Hospitals,
Clinic,
Others
Geography
Asia Pacific,
Europe,
Latin America,
North America,
The Middle East and Africa
Request sample report https://precisionbusinessinsights.com/request-sample?product_id=19058
Major key players in the global meningococcal vaccines market are, GlaxoSmithKline plc. (UK), JN-International Medical Corporation (U.S.), Novartis International AG (Switzerland), Sanofi (France), Pfizer, Inc. (U.S.) and Baxter International, Inc. (U.S.).